Telavancin
0112
Phase 3 small_molecule terminated
Quick answer
Telavancin for Bacteremia is a Phase 3 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CUMBERLAND PHARMACEUTICALS INC
- Indication
- Bacteremia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated